Loading interface...

Fibrolip 200 mg Capsule

Manufactured byEmcure Pharmaceuticals Ltd.
ContainsFenofibrate
Description
Fibrolip 200 mg Capsule is a lipid (fat) lowering medicine. It is used to treat high blood cholesterol and triglycerides (fats) levels. This medicine reduces the levels of bad cholesterol and triglycerides and increases the levels of good cholesterol in your blood. This may further reduce the risk of heart attack or stroke (a condition that causes reduced oxygen supply to the brain). Fibrolip 200 mg Capsule may cause side effects like headache, nausea, vomiting, diarrhoea, etc. Consult your doctor if these sides effects last for a long time. Fibrolip 200 mg Capsule can be taken with or without food as instructed by your doctor. For the ease of remembering, take this medicine around the same time every day. Avoid the discontinuation of Fibrolip 200 mg Capsule without consulting your doctor. Fibrolip 200 mg Capsule is not recommended for use if you are allergic to it. Avoid taking this medicine if you have severe liver or kidney problems, or gallbladder conditions such as gallstones (solid deposits that develop in your gallbladder). Inform your doctor if you are taking any other medicines as they can interact with Fibrolip 200 mg Capsule and cause undesired effects. Fibrolip 200 mg Capsule is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant, or are breastfeeding before taking this medicine.

Side effects

Major & minor side effects for Fibrolip 200 mg Capsule

  • Chills and fever
  • Itching and skin rash
  • Nausea and vomiting
  • Headache
  • Weakness
  • Runny Nose
  • Stuffy Nose
  • Increased sensitivity of the skin to sunlight
  • Muscle pain
  • Diarrhoea

Uses of Fibrolip 200 mg Capsule

What is it prescribed for?

  • Severe hypertriglyceridaemia
  • Hypercholesterolemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time at which Fibrolip 200 mg Capsule starts its action is not clinically known.
  • How long do the effects of this medicine last?
    Fibrolip 200 mg Capsule can remain in your body for around 5 days.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported for Fibrolip 200 mg Capsule.
  • Can this medicine be taken during pregnancy?
    Fibrolip 200 mg Capsule is not recommended during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    It is not known if Fibrolip 200 mg Capsule passes into breastmilk. Therefore, this medicine is not recommended while breastfeeding unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.

Allergy

Fibrolip 200 mg Capsule is not recommended for use if you have a known allergy to it. Seek immediate medical attention if you experience symptoms like skin rashes, redness/swelling (especially of the face, lips, throat, etc.), hives (itchy, painful eruptions that sting), breathing difficulty, etc.

Gallbladder disease

Fibrolip 200 mg Capsule is not recommended for use if you have any conditions affecting your gallbladder such as gallstones (solid deposits that develop in your gallbladder, a small pouch that stores bile produced by the liver). This medicine may further increase the risk of gallstones due to increased excretion of cholesterol into the bile (a fluid produced in the liver that helps in digestion).

Active liver disease

Fibrolip 200 mg Capsule may cause abnormal liver function, swelling of the liver, and liver damage. Hence, this medicine is not recommended for use if you have active liver problems as it may further worsen your condition.

Severe kidney impairment

Fibrolip 200 mg Capsule is not recommended for use if you have severely impaired kidneys as a damaged kidney will not filter the medicine completely out of your body, leading to toxicity.
Warnings for special population

Pregnancy

Fibrolip 200 mg Capsule is not recommended during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

It is not known if Fibrolip 200 mg Capsule passes into breastmilk. Therefore, this medicine is not recommended while breastfeeding unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.
General warnings

Hematologic changes

Fibrolip 200 mg Capsule should be used with caution as it may cause a mild to moderate decrease in the haemoglobin (an iron-containing protein responsible for carrying oxygen), haematocrit (blood test done to measure the proportion of red blood cells in the blood), and white blood cell levels.

Increase in serum creatinine levels

Creatinine is a waste substance that your kidneys normally eliminate from the body. Any change in the creatinine levels in the blood indicates kidney damage. Fibrolip 200 mg Capsule should be used with caution as it may cause an increase in the creatinine levels in your blood. Hence, periodic monitoring of kidney function is recommended while taking this medicine.

Concomitant oral anticoagulants

Fibrolip 200 mg Capsule should be used with caution if you are receiving anticoagulants (medicine that prevents the formation of blood clots) due to the increased risk of excessive bleeding. Your doctor may recommend dose adjustment or another suitable alternative based on your condition.

Use in children

Fibrolip 200 mg Capsule is not recommended for use in children below 18 years of age since the safety and efficacy data are not clinically established.

Missed Dose

If you miss a dose of Fibrolip 200 mg Capsule, take it as soon as you remember it. If it is time for the next scheduled dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Do not take more than the prescribed dose. Seek emergency medical treatment in case of an overdose of Fibrolip 200 mg Capsule.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Repaglinide

Glimepiride

Simvastatin

Lovastatin

Cyclosporine

Disease interactions

Rhabdomyolysis

Rhabdomyolysis is a serious condition that causes the breakdown of muscle tissues. It may lead to complications such as kidney damage. Fibrolip 200 mg Capsule may cause muscle damage in some cases. Hence, this medicine should be used with caution if you have rhabdomyolysis. If you experience any unusual muscle pain, tenderness and weakness, consult your doctor immediately.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Fibrolip 200 mg Capsule with or without food as instructed by your doctor. Do not break, crush or chew the tablet/capsule. Take Fibrolip 200 mg Capsule at the same time every day as it will help you to remember. It may take 2 months to get maximum benefits from this medicine. Make sure to check the expiry date before taking Fibrolip 200 mg Capsule. Keep this medicine away from children and pets. Take a low salt and low-fat diet and exercise regularly for better results. Your doctor may suggest periodic blood tests to check your lipid (fat) levels and other blood components while taking this medicine.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Fibrolip 200 mg Capsule works by increasing the natural lipid (fat) breakdown process with the help of an enzyme. This removes the bad cholesterol and triglycerides from your blood and increases the levels of good cholesterol.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Fibric acid derivatives, Hypolipidaemic agents

Schedule

Schedule H

Drugs, H., 2021. Fenofibrate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 8 September 2021].

https://medlineplus.gov/druginfo/meds/a601052.html>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 8 September 2021].

https://www.medicines.org.uk/emc/files/pil.5780.pdf>

Dailymed.nlm.nih.gov. 2021. FENOFIBRATE CAPSULES, USP. [online] Available at: < [Accessed 8 September 2021].

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=829f5c2e-3329-4644-bccb-267afb678540&type=display>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 8 September 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021612s007lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.